Waldencast plc (NASDAQ:WALD) Stock Position Trimmed by Truxt Investmentos Ltda.

Truxt Investmentos Ltda. lessened its holdings in Waldencast plc (NASDAQ:WALD) by 29.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 757,700 shares of the company’s stock after selling 311,702 shares during the quarter. Waldencast accounts for 4.8% of Truxt Investmentos Ltda.’s investment portfolio, making the stock its 8th largest position. Truxt Investmentos Ltda. owned approximately 0.62% of Waldencast worth $2,947,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in WALD. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Waldencast by 293.9% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock worth $25,000 after purchasing an additional 5,114 shares during the period. SG Americas Securities LLC bought a new stake in shares of Waldencast in the fourth quarter valued at $42,000. Catalina Capital Group LLC purchased a new position in shares of Waldencast during the 3rd quarter valued at $58,000. McAdam LLC purchased a new position in shares of Waldencast during the 3rd quarter valued at $62,000. Finally, Bleakley Financial Group LLC grew its stake in shares of Waldencast by 75.2% during the 3rd quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock worth $96,000 after acquiring an additional 11,288 shares during the period. 41.97% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on WALD. Canaccord Genuity Group started coverage on shares of Waldencast in a research report on Friday, October 25th. They set a “buy” rating and a $5.00 target price for the company. Canaccord Genuity Group raised their price objective on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, November 22nd. DA Davidson boosted their target price on shares of Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a report on Wednesday, December 4th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $6.00 price target on shares of Waldencast in a report on Monday, November 18th. Finally, TD Cowen started coverage on Waldencast in a research report on Monday, December 16th. They issued a “hold” rating and a $4.30 price target for the company. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Waldencast has a consensus rating of “Moderate Buy” and a consensus price target of $5.76.

Waldencast Stock Performance

Waldencast stock opened at $3.03 on Thursday. Waldencast plc has a 1-year low of $2.40 and a 1-year high of $7.88. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21. The firm’s 50 day simple moving average is $3.46 and its 200 day simple moving average is $3.42.

Waldencast Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.